Apellis Pharmaceuticals
APLS
#3546
Rank
ยฃ2.15 B
Marketcap
ยฃ17.19
Share price
-2.09%
Change (1 day)
-61.81%
Change (1 year)

Revenue for Apellis Pharmaceuticals (APLS)

Revenue in 2024 (TTM): ยฃ0.61 Billion

According to Apellis Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.59 Billion. an increase over the revenue in the year 2023 that were of ยฃ0.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Apellis Pharmaceuticals from 2017 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ0.62 B100.02%
2023 ยฃ0.31 B399.33%
2022 ยฃ62.34 M26.43%
2021 ยฃ49.31 M-73.18%
2020 ยฃ0.18 B
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA